HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark A Rubin Selected Research

beta Catenin

2/2006Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.
5/2003Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
5/2002APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark A Rubin Research Topics

Disease

215Prostatic Neoplasms (Prostate Cancer)
06/2022 - 03/2002
204Neoplasms (Cancer)
06/2022 - 03/2002
34Neoplasm Metastasis (Metastasis)
01/2022 - 09/2002
20Disease Progression
01/2022 - 05/2003
17Adenocarcinoma
10/2022 - 05/2002
14Carcinoma (Carcinomatosis)
10/2022 - 01/2003
11Carcinogenesis
02/2016 - 08/2002
10Prostatic Intraepithelial Neoplasia
10/2022 - 04/2002
8Breast Neoplasms (Breast Cancer)
01/2021 - 01/2003
7Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/2011 - 05/2002
6Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 07/2002
6Lymphatic Metastasis
11/2013 - 09/2006
5Inflammation (Inflammations)
01/2016 - 03/2004
5Margins of Excision
05/2013 - 01/2004
4Melanoma (Melanoma, Malignant)
07/2010 - 07/2002
3Noninfiltrating Intraductal Carcinoma (DCIS)
10/2022 - 07/2007
3Genomic Instability
01/2020 - 08/2008
3Lymphoma (Lymphomas)
12/2018 - 07/2002
3Retinoblastoma (Glioblastoma, Retinal)
01/2018 - 12/2006
3Leukemia
09/2017 - 09/2009
3Seminoma
08/2005 - 11/2002
2Ductal Carcinoma
10/2022 - 01/2003
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 06/2017
2Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 09/2002
2Colonic Neoplasms (Colon Cancer)
01/2017 - 08/2002
2Hypersensitivity (Allergy)
01/2017 - 07/2015
2Genetic Translocation (Chromosomal Translocation)
11/2013 - 08/2011

Drug/Important Bio-Agent (IBA)

72Proteins (Proteins, Gene)FDA Link
06/2022 - 03/2002
46Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2002
40AndrogensIBA
10/2022 - 06/2004
33Androgen Receptors (Androgen Receptor)IBA
01/2022 - 09/2005
33Prostate-Specific Antigen (Semenogelase)IBA
01/2018 - 03/2002
32Hormones (Hormone)IBA
01/2021 - 09/2002
30DNA (Deoxyribonucleic Acid)IBA
06/2022 - 04/2002
24RNA (Ribonucleic Acid)IBA
01/2022 - 05/2002
22Transcription Factors (Transcription Factor)IBA
01/2021 - 03/2007
16Messenger RNA (mRNA)IBA
01/2021 - 04/2002
16Biological ProductsIBA
12/2020 - 01/2006
12Complementary DNA (cDNA)IBA
06/2013 - 08/2002
9alpha-methylacyl-CoA racemaseIBA
06/2005 - 07/2002
8Proto-Oncogene Proteins c-etsIBA
02/2013 - 10/2005
7Pharmaceutical PreparationsIBA
01/2022 - 04/2008
7Kazal Pancreatic Trypsin InhibitorIBA
01/2022 - 06/2008
7ChromatinIBA
01/2019 - 07/2010
7AntigensIBA
01/2016 - 05/2002
6Serine Proteases (Serine Protease)IBA
11/2014 - 06/2008
6OligonucleotidesIBA
11/2011 - 08/2002
6LigandsIBA
05/2009 - 10/2004
5Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2021 - 04/2013
5Phenobarbital (Luminal)FDA Link
01/2021 - 01/2017
5Formaldehyde (Formol)FDA Link
01/2018 - 05/2007
5ParaffinIBA
11/2013 - 05/2007
5Tumor Biomarkers (Tumor Markers)IBA
11/2013 - 07/2002
5Keratins (Keratin)IBA
10/2013 - 09/2002
5Monoclonal AntibodiesIBA
07/2010 - 05/2002
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2022 - 05/2013
4TensinsIBA
01/2022 - 05/2013
4Protein Isoforms (Isoforms)IBA
01/2017 - 02/2005
4Cadherins (E-Cadherin)IBA
12/2003 - 01/2003
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 10/2015
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021 - 06/2015
3UbiquitinIBA
01/2021 - 10/2014
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021 - 04/2013
3NucleotidesIBA
12/2020 - 02/2016
3Aurora Kinase AIBA
01/2019 - 01/2013
3abirateroneIBA
11/2018 - 01/2017
3enzalutamideIBA
01/2018 - 01/2017
3Long Noncoding RNAIBA
01/2018 - 03/2014
3PlatinumIBA
01/2017 - 06/2014
3Peptides (Polypeptides)IBA
10/2014 - 09/2005
3Capsules (Microcapsules)IBA
03/2012 - 01/2005
3Coenzyme A (CoA)IBA
02/2012 - 04/2002
3EnzymesIBA
02/2012 - 03/2004
3Racemases and Epimerases (Epimerases and Racemases)IBA
02/2012 - 04/2002
35' Untranslated Regions (5' UTR)IBA
08/2007 - 10/2005
3beta CateninIBA
02/2006 - 05/2002
3Imatinib Mesylate (Gleevec)FDA Link
01/2006 - 09/2004
3Finasteride (Propecia)FDA LinkGeneric
11/2005 - 10/2003
3Fatty Acids (Saturated Fatty Acids)IBA
06/2005 - 03/2004
3AntibodiesIBA
05/2003 - 05/2002
2SolutionsIBA
06/2022 - 01/2009
2Cell-Free Nucleic AcidsIBA
06/2022 - 01/2018
25'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
01/2022 - 03/2012
2Ligases (Synthetase)IBA
01/2021 - 01/2018
2Adenosine Diphosphate (ADP)IBA
01/2020 - 10/2015
2Phosphotransferases (Kinase)IBA
01/2019 - 10/2007
2DesminIBA
01/2018 - 12/2016
2Androgen Antagonists (Antiandrogens)IBA
01/2017 - 05/2009
2Estrogen ReceptorsIBA
12/2016 - 07/2009
2AutoantibodiesIBA
01/2016 - 09/2005
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
09/2015 - 03/2014
2Docetaxel (Taxotere)FDA Link
11/2014 - 02/2005

Therapy/Procedure

67Therapeutics
10/2022 - 08/2002
35Prostatectomy (Retropubic Prostatectomy)
01/2022 - 03/2002
30Castration
01/2022 - 12/2010
13Precision Medicine
01/2022 - 02/2015
10Drug Therapy (Chemotherapy)
05/2021 - 09/2004
5Radiotherapy
04/2014 - 10/2002
4Aftercare (After-Treatment)
01/2022 - 06/2008
3Lasers (Laser)
09/2007 - 03/2006